文献速递颈动脉与弓上血管

放疗诱导性颈动脉狭窄颈动脉支架置入术的远期结局

Late Outcomes of Carotid Artery Stenting for Radiation Therapy-Induced Carotid Stenosis.
PubMed 文献 · J Endovasc Ther · 2022-01-10

这项回顾性多中心研究收集了2005至2017年法国11家学术机构因放疗诱导性颈动脉狭窄行颈动脉支架置入术的112例患者共121例次手术,平均随访42.5±32.6个月,5年无神经事件生存率87.8%、支架内再狭窄率38.9%,糖尿病与术后单一抗血小板治疗为再狭窄显著预测因素。

要点

  • 放疗诱导性颈动脉狭窄支架置入术后5年无神经事件生存率87.8%,支架内再狭窄率38.9%。
  • 糖尿病(p=0.02)与术后单一抗血小板治疗(p=0.001)为支架内再狭窄的显著预测因素。
  • 5年免于靶病变血运重建率91.9%,5年死亡率为23%。

核心结论

  • 颈动脉支架置入术是不适合颈动脉内膜切除术的放疗诱导性狭窄患者的有效选择,远期随访中神经事件与再干预率低。

研究设计与样本

  • 回顾性多中心研究,收集2005至2017年法国11家学术机构因放疗诱导性颈动脉狭窄行颈动脉支架置入术的全部病例,共112例患者、121例次手术。

主要发现

  • 放疗与颈动脉支架置入术的平均间隔为15±12年,31.4%的病例病变有症状。
  • 平均随访42.5±32.6个月(范围1-141个月),5年死亡率为23%。
  • 5年无神经事件生存率为87.8%,5年支架内再狭窄率为38.9%。
  • 糖尿病(p=0.02)与术后单一抗血小板治疗(p=0.001)为支架内再狭窄的显著预测因素。
  • 5年免于靶病变血运重建率为91.9%。

局限性

  • 原文指出该领域证据水平低,表现为样本量小、主要为单中心报告、远期数据少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Carotid artery stenting (CAS) appears as a promising alternative treatment to carotid endarterectomy for radiation therapy (RT)-induced carotid stenosis. However, this is based on a poor level of evidence studies (small sample size, primarily single institution reports, few long-term data). The purpose of this study was to report the long-term outcomes of a multicentric series of CAS for RT-induced stenosis. METHODS: All CAS for RT-induced stenosis performed in 11 French academic institutions from 2005 to 2017 were collected in this retrospective study. Patient demographics, clinical risk factors, elapsed time from RT, clinical presentation and imaging parameters of carotid stenosis were preoperatively gathered. Long-term outcomes were determined by clinical follow-up and duplex ultrasound. The primary endpoint was the occurrence of cerebrovascular events during follow-up. Secondary endpoints included perioperative morbidity and mortality rate, long-term mortality rate, primary patency, and target lesion revascularization. RESULTS: One hundred and twenty-one CAS procedures were performed in 112 patients. The mean interval between irradiation and CAS was 15 ± 12 years. In 31.4% of cases, the lesion was symptomatic. Mean follow-up was 42.5 ± 32.6 months (range 1-141 months). The mortality rate at 5 years was 23%. The neurologic event-free survival and the in-stent restenosis rates at 5 years were 87.8% and 38.9%, respectively. Diabetes mellitus (p=0.02) and single postoperative antiplatelet therapy (p=0.001) were found to be significant predictors of in-stent restenosis. Freedom from target lesion revascularization was 91.9% at 5 years. CONCLUSION: This study showed that CAS is an effective option for RT-induced stenosis in patients not favorable to carotid endarterectomy. The CAS was associated with a low rate of neurological events and reinterventions at long-term follow-up.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Nasr B, Crespy V, Penasse E, et al. Late Outcomes of Carotid Artery Stenting for Radiation Therapy-Induced Carotid Stenosis. J Endovasc Ther. 2022. PMID: 35012391. doi:10.1177/15266028211068757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。